Pyxis Oncology, Inc.

NASDAQ:PYXS

1.2 (USD) • At close July 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -21.158-35.571-21.203-17.301-3.256-15.597-23.049-15.901-19.243-36.101-27.674-25.562-31.38-16.829-14.175-8.146-36.825-4.579-3.191-2.529-2.529
Depreciation & Amortization 0.5520.550.7310.5851.1160.7630.5230.5240.190.1920.20.1590.1580.1580.1590.2170.1130.170.2690.0150.015
Deferred Income Tax 0-2.164000-4.391-1.48-1.26000000.412.562.2111.10000
Stock Based Compensation 3.6312.7732.9812.8714.323.2155.1793.6684.8843.8984.4494.0133.4043.1120.3070.5722.450.0150.0110.0090.009
Change In Working Capital 0-6.6599.40112.303-21.766-2.3081.091.763-12.2095.0712.161-2.638-0.0930.8243.7087.93-5.7861.5720.1160.1980.198
Accounts Receivables 0008-800000000008-80000
Change In Inventory 000000000000000000000
Change In Accounts Payables -2.013-0.01-0.6023.177-1.3650.35-1.544-1.56-0.753-1.885-2.3125.765-9.8964.0330.9740.083-0.4470.441-0.08700
Other Working Capital 0-6.64910.0031.126-12.401-2.6582.6343.3230.7536.9564.473-8.4039.803-3.2092.7347.847-5.3391.1310.2030.1980.198
Other Non Cash Items 019.617-6.575-1.465-1.1243.0640.1540.175-0.4639.5530.3070.3160.2320.1560.1530.07820.217-0.3450.1410.1760.176
Operating Cash Flow -22.535-19.29-14.665-3.007-20.71-15.254-17.583-11.031-26.841-17.387-20.557-23.712-27.679-12.169-7.2882.862-18.731-3.167-2.654-2.132-2.132
Investing Activities:
Investments In Property Plant And Equipment 0000-0.2370-0.061-2.259-4.406-1.858-4.266-0.129-0.146-0.4010-0.371-0.1690-0.139-0.672-0.672
Acquisitions Net 000000.0016.659-15.193000000.0500-0.050000
Purchases Of Investments -51.352-4.37-23.643-39.312-92.793-10.227-56.428-35.189-94.987000000000000
Sales Maturities Of Investments 031.027-113.84839.31674.53220.45456.40115.1930000000000000
Other Investing Activites 67.1730137.4830-18.2610.01-015.193-0.0950000-0.100-0.050000
Investing Cash Flow 15.82126.657-0.0080.004-18.49810.2286.571-22.255-99.393-1.858-4.266-0.129-0.146-0.4510-0.371-0.2190-0.139-0.672-0.672
Financing Activities:
Debt Repayment 000000000000000000000
Common Stock Issued 0.00201.584057.7070.0270.2226.12200.1830.0060.0010.176152.2960000.032000
Common Stock Repurchased 000.239-0.043-0.196-0-000000000000000
Dividends Paid 000000000000000000000
Other Financing Activities 00.1290.0710.110.049-0.025-0.1710.0030-0.0060.0060.0010.1762.604-1.708-0.682151.534-0.0310.0310.0020.002
Financing Cash Flow 00.1291.6550.1157.511-0.025-0.1716.12500.1770.0060.0010.176154.9-1.708-0.682151.5340.0010.0310.0020.002
Other Information:
Effect Of Forex Changes On Cash 000000000-0.177000-137.15600000.00100
Net Change In Cash -6.7147.417-13.018-2.89318.303-5.051-11.183-27.161-126.234-19.245-24.817-23.84-27.649142.73-8.9951.809132.584-3.167-2.761-2.802-2.802
Cash At End Of Period 14.23120.94513.52826.54629.43911.13616.18727.3754.531180.765200.01224.827248.667276.316133.586142.581140.7728.18811.35514.116-2.802